Nicholas Mank

Title: Innovations by Inventor Nicholas Mank

Introduction

Nicholas Mank is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of immunology, particularly in the development of innovative vaccine technologies. With a total of 2 patents, Mank's work focuses on enhancing immune responses against various pathogens.

Latest Patents

Mank's latest patents include "Immunogenic compositions comprising nanoemulsion and hepatitis B virus immunogen and methods of using the same." This invention provides methods and compositions for stimulating immune responses, specifically targeting Hepatitis B virus (HBV). The compositions are applicable in both therapeutic and preventative medicine, including vaccination and research applications.

Another significant patent is "Multivalent nanoemulsion vaccines." This invention outlines methods for inducing immune responses against multiple pathogens, such as vaccinia virus, H5N1 influenza virus, Hepatitis B, and HIV. The compositions developed in this patent are also intended for use in clinical and research settings.

Career Highlights

Nicholas Mank is affiliated with the University of Michigan, where he continues to advance his research in immunology and vaccine development. His work has the potential to impact public health significantly by providing new avenues for disease prevention.

Collaborations

Mank collaborates with esteemed colleagues, including James R Baker, Jr and Paul E Makidon. These partnerships enhance the scope and impact of his research efforts.

Conclusion

Nicholas Mank's innovative contributions to vaccine technology demonstrate his commitment to improving public health through scientific research. His patents reflect a dedication to developing effective immunogenic compositions that can lead to better health outcomes.